Christina Parker
Papers
2
Total Citations
495
H-Index
2
About
Dr. Christina Parker is a leading clinical researcher in head and neck oncology, whose work has fundamentally shaped treatment paradigms for oropharyngeal squamous cell carcinoma (OPSCC). Her primary research areas focus on comparative effectiveness trials between radiotherapy and transoral robotic surgery, aiming to optimize curative-intent treatments while minimizing patient morbidity. Dr. Parker is best known as the principal investigator of the landmark ORATOR trial, a phase 2 randomized study that directly compared radiotherapy to transoral robotic surgery and neck dissection for OPSCC. The initial 2019 publication of this work has garnered over 458 citations, establishing it as a cornerstone reference in the field. Her subsequent 2024 report of the trial’s final five-year outcomes, with 37 citations, provided crucial long-term data on survival and functional outcomes. By generating high-level evidence in a domain historically reliant on retrospective data, Dr. Parker has empowered clinicians and patients to make more informed, shared decisions. Her rigorous, practice-changing contributions have made her a pivotal figure in the ongoing debate between surgical and non-surgical management of oropharyngeal cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2